outperform price
best yet come rais pt
strong sale assert guidanc abat
bear fear immin rebas colgat wasnt
spend enough
much price
reinvest risk remain concern rebas theori
overlook colgat deceler reflect share
loss premium oral care product natur therapeut
lifestyl power e-commerce
work indic along support slide
follow oral care remain one attract stapl
categori term growth potenti profit
colgat new product pipelin pivot digit
hello acquisit reassert firm leadership
also like colgat diversif skincar
dermatologist-cent busi
model moreov credibl growth platform skincar could
correct colgat relianc latin america pave way
greater exposur asia
factor give us confid rais pt
make cl top larg cap pick next month
what chang ceo wallac put colgat cant
one brand us repres major chang
strategi analog what happen ko
common thread behind follow
increas support toward tom main on-line
expans premium swiss line gaba brazil
roll offlin global potenti
acceler e-commerce sale growth
hill-u grow doubl digit cl capit vet
hill home subscript model increas
support specialti retail follow giss decis
distribut buffalo mass retail
chang yet turnaround
next month colgat trend scanner data wont
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest decis
bear mind toothpast scanner data account
colgat global sale time product launch competit action
expans smile direct club whiten toothpast
ep growth consensu reflect
increas reinvest fund initi support mid-
accret filorga acquisit
macro screen rel benign although weaken brazilian currenc
issu
rais pt pleas refer exhibit friday move cl
trade premium share averag premium
assum regress back histor premium reflect colgat
high exhibit invest growth opportun price-to-earnings
get price target
exhibit invest capit vs roic-wacc gap colgat earn highest return invest capit stapl cl share
compani file isi analysi estim
rel stapl xlp
trade-up drive growth toothpast
pt
colgat regain share
colgat total restag drove pt posit mix
howev benefit total wane
time promo pg contribut weak
volum promot cl fell pg increas
much price cl problem whether
colgat brand premium
 toothpast price colgat retail discount crest averag
colgat innov target whiten largest
segment toothpast market
 toothpast share type
whiten toothpast lag natur
volum growth toothpast type
colgat total
pg cl lead teeth whiten technolog
share toothpast segment
therapeut multi
gsk-sensodyn outperform cl whose push
therapeut oral care elmex still small
whiten trend consum
oral health
whiten also get attent back
retail question expens
sdc go
cl tom main lead natur toothpast
cl tom declin competit increas
sale natur toothpast acceler
tom main
tom main
valu share index offlin
tom main
amazon share retail cpg product
colgat new product natur segment
 vegan past recycl tube
made chocol
 toothbrush grow
cl mostli play manual toothbrush
consum trade electr devic unclear
sale brush head fall
sale growth segment track off-lin channel
power smart toothbrush fit sensor camera led detect dental plaqu
automat power programm devic analyz data receiv provid
real time indic brush guidanc user
current state art smart-toothbrush
metal
tom main
arriv target per cl share base rel intrins valuat methodolog discount cash
flow model point fair valu per share use wacc growth termin valu base
project ep compound-annual-growth-rate target impli forward price-to-earnings
premium today xlp stapl sector multipl
pt impli regress mean share trade rang re-rat cl share histor averag
predic convict health global oral care market colgat capac recalibr portfolio
busi model restart market share gain widen leadership believ challeng pressur cl
valuat structur expens deal street fear like manag restructur
save back-end load cl afford higher reinvest power
there limit downsid risk given cl trade one standard deviat trade averag vs stapl
sector model assum improv macro environ brazil key profit center firm colgat
success diversifi portfolio natur therapeut oral care howev greatest risk stem increas
competit busi outsid oral care home care person care categori colgat lack financi
incent reinvest structur part cl person care busi becom less attract colgat person care
busi compos region brand miss structur premium categori
articl articl
time dissemin februari
analyst yutong zhou javier escalant robert ottenstein primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
